Mitochondria and polycystic ovary syndrome: The role of ferroptosis, inflammasomes, and endoplasmic reticulum stress. [PDF]
Zhang X +5 more
europepmc +1 more source
Neuroinflammation in Alzheimer's Disease (AD) and Glioblastoma (GBM): Shared Mechanisms and Therapeutic Insights. [PDF]
Mikołajczak K, Chmiel J, Leszek J.
europepmc +1 more source
Inflammasome activation dictates the efficacy of antimycobacterial activity of frontline TB drugs. [PDF]
Singh A +5 more
europepmc +1 more source
The Multifaceted Role of Pyroptosis: Molecular Mechanisms, Crosstalk with Other Cell Death Pathways, and Therapeutic Implications. [PDF]
Boaru DL +18 more
europepmc +1 more source
The NLRP3-α-Synuclein Circuit: A Core Driver and Therapeutic Target in Parkinson's Disease. [PDF]
Liu K, He Z, Zhang L, Wu YM, Xiao L.
europepmc +1 more source
Human non-canonical inflammasomes activate CASP3 to limit intracellular Salmonella replication in macrophages. [PDF]
Kulkarni M +13 more
europepmc +1 more source
Pharmacological effects of gastrodin include prevention and treatment of cognitive decline and reperfusion injuries, anticonvulsion, antiepilepsy, antidepressants, and analgesia, which are related to antiferroptosis and antipyroptosis. Abstract Gastrodin, as an effective monomer of gastrodia elata, plays a significant role in anti‐inflammatory ...
Xue Zheng, Jing Li, Zhao‐Qiong Zhu
wiley +1 more source
Research progress on the role of inflammatory mediators in the pathogenesis of epilepsy
In the central nervous system, activated immune cells lead to the overproduction of inflammatory mediators through the corresponding signal pathway. Under the stimulation of inflammatory factors, neuroinflammation ultimately occurs. Overexpression of inflammatory mediators and activated immunocytes plays an important role in the emergence and ...
Yue Yu, Fei‐Ji Sun
wiley +1 more source
MircoRNAs as regulators of regulated cell death in cancer progression: a focus on ferroptosis, anoikis and pyroptosis. [PDF]
Xiao D +7 more
europepmc +1 more source
ABSTRACT Despite substantial clinical benefit from immune checkpoint inhibitors (ICI), advanced melanoma remains challenging due to frequent treatment resistance. Resistance may be intrinsic (primary) or emerge over time (secondary). Biomarkers predicting distinct resistance phenotypes before therapy are lacking.
Julian Kött +17 more
wiley +1 more source

